Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Legal Battles Over Labeling Continue Between Generic And Brand-Name Manufacturers
Bidness Etc.
Monday, September 8, 2014 - 8:01am
tags:
generics, Merck, Fosamax
Why Is Novartis Investing in This $49 Billion Market?
Motley Fool
Monday, September 8, 2014 - 7:58am
tags:
Novartis, mobile apps
Report: Google's Calico going on hiring spree after AbbVie tie-up
Fierce Biotech
Monday, September 8, 2014 - 7:56am
tags:
AbbVie, Google, Calico, hirings
AstraZeneca's self-styled 'blockbuster' benralizumab tanks in severe COPD study
Fierce Biotech
Monday, September 8, 2014 - 7:55am
tags:
AstraZeneca, benralizumab, COPD
Why Valeant's Hostile Takeover Bid of Allergan Is Bad for Shareholders
TheStreet.com
Monday, September 8, 2014 - 7:50am
tags:
Allergan, Valeant Pharmaceuticals, M&A
Keryx Bear Case Bolstered by Less-Than-Zippy 'Zerenex' Label
TheStreet.com
Monday, September 8, 2014 - 7:49am
tags:
Keryx, Zerenex
Is there a cure for pharma’s innovation problem?
CNBC
Monday, September 8, 2014 - 7:48am
tags:
innovation
Leading Anti-Marijuana Academics Are Paid By Painkiller Drug Companies
Vice
Sunday, September 7, 2014 - 11:26am
tags:
marijuana, Medical Marijuana, pain management
Synthetic Biologics Highlights New Data from C. difficile Program Presented at the 54th ICAAC
Yahoo/PR Newswire
Sunday, September 7, 2014 - 10:48am
tags:
Synthetic Biologics, C. difficile, P3A, P4A
BioCryst Announces RAPIVAB(TM) Trial Results for the Treatment of Influenza at the ICAAC 2014 Meeting
Yahoo/Globe NewsWire
Sunday, September 7, 2014 - 10:44am
tags:
Biocryst, Rapivab, influenza
Novavax Presents Data on RSV F Nanoparticle Vaccine Induced Monoclonal Antibody at ICAAC
Yahoo/Globe NewsWire
Sunday, September 7, 2014 - 10:41am
tags:
Novavax, RSV F vaccine
Study Shows Immigrants Hold Key Jobs in U.S. Pharma Sector
India West, India
Saturday, September 6, 2014 - 9:43am
tags:
FDA approves Keryx's kidney drug with warnings, shares fall
Yahoo/Reuters
Saturday, September 6, 2014 - 9:25am
tags:
Keryx, ferric citrate, chronic kidney disease
Mallinckrodt's Pain Therapy Hits Phase III Primary Endpoint
Yahoo/Zacks
Saturday, September 6, 2014 - 9:20am
tags:
Mallinckrodt, pain management, MNK-155
Halozyme's PEGPH20 Program Gains Fast Track Designation
Yahoo/Zacks
Saturday, September 6, 2014 - 9:18am
tags:
Halozyme, PEGPH20, metastatic pancreatic cancer, pancreatic cancer
Why Gilead Is Falling On Drugs For Developing Nations
Investor's.com
Saturday, September 6, 2014 - 9:17am
tags:
Gilead Sciences
Merck's Anti-PD-1 Drug Keytruda First to be Launched in US
Yahoo/Zacks
Saturday, September 6, 2014 - 9:11am
tags:
Keytruda, Merck, melanoma
J&J Ordered to Pay $3.27 Million Over Mesh Implant
Bloomberg
Friday, September 5, 2014 - 4:06pm
tags:
pelvic mesh, JNJ, devices, Ethicon
Bristol-Myers Sues Merck Over Cancer Immunotherapy Patent
Bloomberg
Friday, September 5, 2014 - 4:02pm
tags:
Bristol-Myers Squibb, Merck, Keytruda
Huntington’s Disease Orphan Drug Designation Could Rescue Prana Read more: Huntington's Disease Orphan Drug Designation Could
24/7 Wall St
Friday, September 5, 2014 - 3:59pm
tags:
Huntington's disease, orphan drugs, Prana Biotechnology

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.